Developmental expression of ACE2 in the SHR kidney: A role in hypertension?

Kidney International

Volumn 70, Issue 1, 2006, Pages 34-41

  Tikellis, C ^a   Cooper, M E ^a   Bialkowski, K ^a   Johnston, C I ^a   Burns, W C ^a   Lew, R A ^a   Smith, A I ^a   Thomas, M C ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

ACE; ACE2; Hypertension; RAS; Spontaneously hypertensive rat

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GLOMERULUS FILTRATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; PATHOGENESIS; PHOTOCHEMICAL QUENCHING; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; GENE EXPRESSION REGULATION; HYPERTENSION, RENAL; KIDNEY; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RNA, MESSENGER;

EID: 33745725913     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000428     Document Type: Article

References (40)

1. Obata J, Nakamura T, Takano H et al. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats. J Hypertens 2000; 18: 1247-1255.
2. Harrap SB, Mirakian C, Datodi SR et al. Blood pressure and lifespan following brief ACE inhibitor treatment in young spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1994; 21: 125-127.
3. Turner AJ, Hiscox JA, Hooper NM. ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci 2004; 25: 291-294.
4. Donoghue M, Hsieh F, Baronas E et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000; 87: E1-E9.
5. Tipnis SR, Hooper NM, Hyde R et al. A human homolog of angiotensin-converting enzyme - cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000; 275: 33238-33243.
6. Vickers C, Hales P, Kaushik V et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002; 277: 14838-14843.
7. Ferrario CM, Chappell MC. Novel angiotensin peptides. Cell Mol Life Sci 2004; 61: 2720-2727.
8. Thomas MC, Tikellis C. ACE2; an ACE up the sleeve? Curr Enz Inhib 2005; 1: 35-56.
9. Zhong JC, Huang DY, Yang YM et al. Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats. Hypertension 2004; 44: 907-912.
10. Crackower MA, Sarao R, Oudit GY et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002; 417: 822-828.
11. Welsch C, Giesen-Crouse EM, Schmidt M et al. Tissue converting enzyme activity is low in the kidney of spontaneously hypertensive rats. J Cardiovasc Pharmacol 1987; 10(Suppl 7): S129-S132.
12. Tikellis C, Johnston CI, Forbes JM et al. Identification of angiotensin converting enzyme 2 in the rodent retina. Curr Eye Res 2004; 29: 419-427.
13. Matsushima Y, Kawamura M, Akabane S et al. Increases in renal angiotensin II content and tubular angiotensin II receptors in prehypertensive spontaneously hypertensive rats. J Hypertens 1988; 6: 791-796.
14. Campbell DJ, Duncan AM, Kladis A et al. Angiotensin peptides in spontaneously hypertensive and normotensive Donryu rats. Hypertension 1995; 25: 928-934.
15. Correa FM, Viswanathan M, Ciuffo GM et al. Kidney angiotensin II receptors and converting enzyme in neonatal and adult Wistar-Kyoto and spontaneously hypertensive rats. Peptides 1995; 16: 19-24.
16. Li N, Zimpelmann J, Cheng K et al. The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules. Am J Physiol Renal Physiol 2005; 288: F353-F362.
17. Brosnihan KB, Neves LA, Joyner J et al. Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy. Hypertension 2003; 42: 749-753.
18. Gouldsborough I, Ashton N. Maternal environment alters renal response to angiotensin II in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 2001; 28: 504-509.
19. Norrelund H, Christensen KL, Samani NJ et al. Early narrowed afferent arteriole is a contributor to the development of hypertension. Hypertension 1994; 24: 301-308.
20. Ferrario CM, Averill DB, Brosnihan KB et al. Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat. Kidney Int 2002; 62: 1349-1357.
21. Tikellis C, Johnston CI, Forbes JM et al. Characterization of renal Angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 2003; 41: 392-397.
22. Vauquelin G, Michotte Y, Smolders I et al. Cellular targets for angiotensin II fragments: pharmacological and molecular evidence. J Renin Angiotensin Aldosterone Syst 2002; 3: 195-204.
23. Paula RD, Lima CV, Khosla MC et al. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension 1995; 26: 1154-1159.
24. Brosnihan KB, Li P, Ferrario CM. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 1996; 27: 523-528.
25. Li P, Chappell MC, Ferrario CM et al. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension 1997; 29: 394-400.
26. Jaiswal N, Diz DI, Chappell MC et al. Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Characterization of receptors. Hypertension 1992; 19: II49-II55.
27. Muthalif MM, Benter IF, Uddin MR et al. Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells. J Pharmacol Exp Ther 1998; 284: 388-398.
28. O'Sullivan JB, Harrap SB. Resetting blood pressure in spontaneously hypertensive rats. The role of bradykinin. Hypertension 1995; 25: 162-165.
29. Yosipiv IV, el-Dahr SS. Developmental regulation of ACE gene expression by endogenous kinins and angiotensin II. Am J Physiol 1995; 269: F172-F179.
30. Marquez MG, Cabrera I, Serrano DJ et al. Cell proliferation and morphometric changes in the rat kidney during postnatal development. Anat Embryol (Berl) 2002; 205: 431-440.
31. Oliverio MI, Kim HS, Ito M et al. Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc Natl Acad Sci USA 1998; 95: 15496-15501.
32. Nishimura H, Yerkes E, Hohenfellner K et al. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell 1999; 3: 1-10.
33. Kihara M, Umemura S, Sumida Y et al. Genetic deficiency of angiotensinogen produces an impaired urine concentrating ability in mice. Kidney Int 1998; 53: 548-555.
34. Hilgers KF, Reddi V, Krege JH et al. Aberrant renal vascular morphology and renin expression in mutant mice lacking angiotensin-converting enzyme. Hypertension 1997; 29: 216-221.
35. Russo LM, Brammar GC, Jerums G et al. The effect of ramipril on albumin excretion in diabetes and hypertension: the role of increased lysosomal activity and decreased transforming growth factor-beta expression. J Hypertens 2003; 21: 419-428.
36. Bunag RD. Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol 1973; 34: 279-282.
37. Johnston H, Koukoulas I, Jeyaseelan K et al. Ontogeny of aquaporins 1 and 3 in ovine placenta and fetal membranes. Placenta 2000; 21: 88-99.
38. Bonnet F, Cooper ME, Kawachi H et al. Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension. Diabetologia 2001; 44: 874-877.
39. Friedland J, Silverstein E. A sensitive fluorimetric assay for serum angiotensin-converting enzyme. Am J Clin Pathol 1976; 66: 416-424.
40. Dales NA, Gould AE, Brown JA et al. Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors. J Am Chem Soc 2002; 124: 11852-11853.